ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,406,621 | +14.4% | 7,898,583 | 0.0% | 0.39% | +29.3% |
Q2 2023 | $21,326,174 | -9.1% | 7,898,583 | 0.0% | 0.30% | -10.6% |
Q1 2023 | $23,458,792 | +17.9% | 7,898,583 | 0.0% | 0.34% | +28.8% |
Q4 2022 | $19,904,429 | +85.4% | 7,898,583 | +33.9% | 0.26% | +71.4% |
Q3 2022 | $10,736,000 | -32.0% | 5,898,583 | +17.7% | 0.15% | -30.9% |
Q2 2022 | $15,781,000 | -49.3% | 5,009,714 | -0.5% | 0.22% | -38.2% |
Q1 2022 | $31,115,000 | -56.5% | 5,034,814 | 0.0% | 0.36% | -51.0% |
Q4 2021 | $71,495,000 | +77.5% | 5,034,814 | 0.0% | 0.74% | +80.2% |
Q3 2021 | $40,279,000 | -42.7% | 5,034,814 | +104.7% | 0.41% | -40.4% |
Q2 2021 | $70,277,000 | +32.5% | 2,459,814 | +34.7% | 0.69% | +22.3% |
Q1 2021 | $53,040,000 | – | 1,825,814 | – | 0.56% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |